Condition: Ulcerative Colitis (UC) · Ulcerative Colitis, Active Moderate · Ulcerative Colitis, Active Severe · Sponsor: Eli Lilly and Company
The main purpose of this study is to evaluate the safety and effectiveness of LY4268989 when compared to placebo in adult participants with moderately to severely active ulcerative colitis (UC). The study drug will be administered orally. The study will last up to approximately 108 weeks, excluding screening.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Valleywise Health Medical Center | Phoenix, Arizona, United States | Recruiting |
| One of a Kind Clinical Research Center | Scottsdale, Arizona, United States | Suspended |
| Clinnova Research | Anaheim, California, United States | Recruiting |
| GMC Clinical Research | Folsom, California, United States | Recruiting |
| Om Research LLC | Temple City, California, United States | Recruiting |
| Om Research LLC | Victorville, California, United States | Recruiting |
| Peak Gastroenterology Associates | Colorado Springs, Colorado, United States | Recruiting |
| Advanced Research Institute - Denver | Denver, Colorado, United States | Suspended |
| Rocky Mountain Gastroenterology Associates - Lakewood | Lakewood, Colorado, United States | Recruiting |
| Medical Research Center of Connecticut | Hamden, Connecticut, United States | Not Yet Recruiting |
| K2 Medical Research - Daytona Beach | Daytona Beach, Florida, United States | Recruiting |
| Clinical Research of Osceola | Kissimmee, Florida, United States | Recruiting |
+ 246 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07415044